Anna Kron
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Treatments and Mutations 33
- Lung Cancer Diagnosis and Treatment 3
-
- Antifungal resistance and susceptibility 2
- COVID-19 Clinical Research Studies 2
- Co-authors
- Florian Kron (18 shared papers)Juergen Wolf (9 shared papers)Reinhard Buettner (4 shared papers)Svenja Wagener‐Ryczek (4 shared papers)Sabine Merkelbach‐Bruse (10 shared papers)Christina Alidousty (4 shared papers)Anne Maria Schultheis (4 shared papers)Carina Heydt (5 shared papers)
- Journals
- Annals of Oncology (7 papers)Journal of Thoracic Oncology (5 papers)Lung Cancer (2 papers)Clinical Cancer Research (2 papers)Mycoses (2 papers)
- Partner nations
- GermanyAustraliaUnited Kingdom
In The Last Decade
Anna Kron
41 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 61
- Pulmonary and Respiratory Medicine 727
- Oncology 139
- Cancer Research 83
- Hematology 37
- Health Informatics 6
Countries citing papers authored by Anna Kron
This map shows the geographic impact of Anna Kron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kron more than expected).
Fields of papers citing papers by Anna Kron
This network shows the impact of papers produced by Anna Kron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kron. The network helps show where Anna Kron may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Kron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 216 | |
| 2 | 2018 | 143 | |
| 3 | 2018 | 134 | |
| 4 | 2018 | 117 | |
| 5 | 2019 | 108 | |
| 6 | 2020 | 58 | |
| 7 | 2018 | 49 | |
| 8 | 2019 | 32 | |
| 9 | 2017 | 29 | |
| 10 | 2018 | 22 | |
| 11 | 2019 | 21 | |
| 12 | 2023 | 21 | |
| 13 | 2023 | 15 | |
| 14 | 2020 | 12 | |
| 15 | 2018 | 10 | |
| 16 | 2022 | 10 | |
| 17 | 2021 | 9 | |
| 18 | 2017 | 8 | |
| 19 | 2025 | 8 | |
| 20 | 2020 | 7 |
About Anna Kron
Anna Kron is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Economics and Econometrics, Oncology and Hematology, having authored 49 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (33 papers), Pharmaceutical Economics and Policy (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Antifungal resistance and susceptibility (2 papers), COVID-19 Clinical Research Studies (2 papers), Economic and Financial Impacts of Cancer (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (727 citations), Oncology (139 citations), Cancer Research (83 citations), Hematology (37 citations) and Health Informatics (6 citations). Anna Kron has collaborated with scholars based in Germany, Australia and United Kingdom. Frequent co-authors include Florian Kron, Juergen Wolf, Reinhard Buettner, Svenja Wagener‐Ryczek, Sabine Merkelbach‐Bruse, Christina Alidousty, Anne Maria Schultheis, Carina Heydt, Michael J. Hallek and Elke Binot. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer, Clinical Cancer Research and Mycoses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.